Form D · Biotechnology

Syncromune, Inc.

Fort Lauderdale, FL · CIK 0001955312

Offering snapshot reported May 11, 2026 · SEC filing

Reported sold
$145M
Offering amount: $145M
Investors reported
77
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 3, 2024
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$72.4M$145MAug 21, 2025: $111,828,793.00Aug 21, 2025May 11, 2026: $144,828,791.00May 11, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$111,828,793 → $144,828,791

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 11, 2026Amendment$144,828,791$32,999,998vs Aug 21, 202577SEC filing
Aug 21, 2025Amendment$111,828,793No comparison77SEC filing
Dec 17, 2024Initial$50,828,889No comparison78SEC filing
Oct 6, 2023Amendment$14,180,000$8,870,000vs Nov 29, 202244SEC filing
Nov 29, 2022Initial$5,310,000No comparison16SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-532273
Total Offering Amount and Total Amount Sold each includes the conversion of outstanding convertible securities.

Source: Form D, filed May 11, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Gregory J. Champion Executive
Jeffrey L. Cleland Director
Stephen Dale Executive
Agustin Gago Executive
Joseph Gerardi Executive
Eamonn Hobbs Director, Executive
Jeffrey Kraws Executive
Charles J. Link Director, Executive
Joseph C. Maroon Director
Kerri Ann Millar Executive
Norman Schwartz Director
Douglas G. Watson Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
2919 E. Commercial Blvd., Suite 200
Fort Lauderdale, FL, 33308